nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.01.2009 | Letter to the Editor

Drug enhancement of myocardial tracer uptake during myocardial perfusion imaging

verfasst von: Panagiotis Georgoulias, Varvara Valotassiou, Ioannis Tsougos

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Ergün EL, Caglar M, Bozkurt MF, Ergün H. ^99mTc sestamibi myocardial perfusion scintigraphy with the novel use of metamizol for the detection of perfusion reversibility. Eur J Nucl Med Mol Imaging 2008;35:1530–6.PubMedCrossRef

Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992;33:505–11.PubMed

Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992;33:1925–30.PubMed

Sawada SG, Allman KC, Muzik O, Beanlands RS, Wolfe ER Jr, Gross M, et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994;23:92–8.PubMedCrossRef

Sciagrà R, Bisi G, Santoro GM, Zerauschek F, Sestini S, Pedenovi P, et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting post-revascularization recovery. J Am Coll Cardiol 1997;30:384–91.PubMedCrossRef

Leoncini M, Sciagrà R, Bellandi F, Maioli M, Sestini S, Marcucci G, et al. Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy. J Nucl Cardiol 2002;9:402–6.PubMedCrossRef

Russell RR, Zaret LB. Nuclear cardiology: present and future. Curr Probl Cardiol 2006;31:557–629.PubMedCrossRef

Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med 2005;32:855–97.CrossRef

Georgoulias P, Demakopoulos N, Kontos A, Xaplanteris P, Xydis K, Fezoylidis I. Early post-stress pulmonary uptake of 99mTc tetrofosmin during exercise (SPECT) myocardial perfusion imaging: correlation with haemodynamic, perfusion and function parameters. Nucl Med Commun 2006;27:119–26.PubMedCrossRef

10.

Georgoulias P, Demakopoulos N, Orfanakis A, Xydis K, Xaplanteris P, Vardas P, et al. Evaluation of abnormal heart-rate recovery after exercise testing in patients with diabetes mellitus: correlation with myocardial SPECT and chronotropic parameters. Nucl Med Commun 2007;28:165–71.PubMedCrossRef

11.

Jensen KM, Dahl JB. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites. Arzneimittelforschung 1994;44:951–3.PubMed

Titel: Drug enhancement of myocardial tracer uptake during myocardial perfusion imaging
verfasst von: Panagiotis Georgoulias
Varvara Valotassiou
Ioannis Tsougos
Publikationsdatum: 01.01.2009
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2009
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-008-0974-z

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Calculation of electron dose to target cells in a complex environment by Monte Carlo code “CELLDOSE”

Society communications

A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours

The important role of audits, surveys and interobserver reproducibility studies in continuing education in nuclear medicine

Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts